Vical to Present at the Leerink Global Healthcare Conference
10 February 2015 - 12:30PM
Vical Incorporated (Nasdaq:VICL) today announced that the company
will participate in a fireside chat discussion at the Leerink
Global Healthcare Conference in New York. The discussion is
scheduled for Wednesday, February 11th at 2:15 p.m. Eastern Time. A
webcast of the company's discussion will be available live and
archived through the Events & Presentations page in the
Investors section of the Vical website at www.vical.com.
About Vical
Vical researches and develops biopharmaceutical products
leveraging its patented DNA delivery technologies for the
prevention and treatment of chronic or life-threatening infectious
diseases. In addition, the company has collaborations with major
pharmaceutical and biotechnology companies focused on addressing
significant unmet medical needs. Additional information on Vical is
available at www.vical.com.
This press release contains forward-looking statements subject
to risks and uncertainties that could cause actual results to
differ materially from those projected. Forward-looking statements
include statements about the company's focus, collaborative
partners, product candidates, and developmental status. Risks and
uncertainties include whether any product candidates will be shown
to be safe and efficacious in clinical trials, the timing of
clinical trials, whether Vical or its collaborative partners will
seek or gain approval to market any product candidates, the
dependence of the company on its collaborative partners, and
additional risks set forth in the company's filings with the
Securities and Exchange Commission. These forward-looking
statements represent the company's judgment as of the date of this
release. The company disclaims, however, any intent or obligation
to update these forward-looking statements.
CONTACT: Andrew Hopkins
(858) 646-1127
Website: www.vical.com
Vical (NASDAQ:VICL)
Historical Stock Chart
From Apr 2024 to May 2024
Vical (NASDAQ:VICL)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Vical Inc (NASDAQ): 0 recent articles
More News Articles